Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Chemocentryx Inc (NQ: CCXI ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Oct 19, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Chemocentryx Inc < Previous 1 2 3 4 5 6 7 8 9 Next > Two Down With Sanofi Bowing Out From Horizon Buyout Talks, Amgen Agrees To Buy For $116.5/Share December 12, 2022 Via Benzinga How to Trade the High-Growth Biotech Sector in the Midst of a Bear Market November 23, 2022 Biotech is an exciting and emerging space that’s attracted increasing investor interest in recent years. Via Benzinga ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings October 17, 2022 From ChemoCentryx, Inc. Via GlobeNewswire Biotech Stocks Well-Positioned For The Fourth Quarter October 12, 2022 The path of interest rates is clearer for 2022 and the FED is closer to a pause early next year as it calibrates its response from a hammer approach so far. Via Talk Markets ChemoCentryx: Q2 Earnings Insights August 09, 2022 ChemoCentryx (NASDAQ:CCXI) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Via Benzinga 3 Analysts Have This to Say About ChemoCentryx August 05, 2022 ChemoCentryx (NASDAQ:CCXI) has observed the following analyst ratings within the last quarter: Via Benzinga ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting October 05, 2022 From ChemoCentryx, Inc. Via GlobeNewswire These Were the Five Best And Worst Performing Mid-Cap Stocks In August 2022 September 20, 2022 We have used the August return data from finviz.com to come up with the five best and worst performing mid-cap stocks in August 2022. Via Talk Markets Here Are 10 Biotech Stocks — Including Catalyst And Viridian — That Would Have Netted You $10,000 More This Year September 19, 2022 The biotech run off a June bottom is great — until you realize you could've netted more. Via Investor's Business Daily Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin September 15, 2022 The market is struggling, yet biotech stocks are acting like it's good times again. Here's why. Via Investor's Business Daily INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates ChemoCentryx, Inc.’s Directors and Officers for Breach of Fiduciary Duties – CCXI September 13, 2022 From Scott+Scott Attorneys at Law LLP Via Business Wire 7 Dow Stocks With Superior Fundamentals September 06, 2022 Robust Dow stocks offer attractive deals for patient investors amidst an unstable economic environment Via InvestorPlace Healthcare Sector Still Looks Good But Lacks Momentum September 06, 2022 The summer rally is over it’s a holiday weekend with low trading volume and bad news is pervasive. A decent jobs report on Friday brought in buyers in early hours until Russia intervened with a Nord... Via Talk Markets ChemoCentryx's Return On Capital Employed Insights September 01, 2022 According to data from Benzinga Pro, during Q2, ChemoCentryx's (NASDAQ:CCXI) reported sales totaled $11.76 million. Despite a 18.02% increase in earnings, the company posted a loss of $31.65 million. Via Benzinga INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates ChemoCentryx, Inc.’s Directors and Officers for Breach of Fiduciary Duties – CCXI August 30, 2022 From Scott+Scott Attorneys at Law LLP Via Business Wire 10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others August 29, 2022 These names are benefitting from M&A, clinical data and promising regulatory actions. Via Investor's Business Daily Whither Small Caps After Fed’s Tough Talk? August 29, 2022 For now its better not to “Fight the Fed” because they are fighting the with the market. Now that everyone is scared of the Fed's rhetoric it would be better to wait a week or so as more data and... Via Talk Markets Blistering-Hot Biotech Shopping Spree Continues: Alcon To Buy Aerie For $770 Million August 23, 2022 The biopharma buying spree continued Tuesday with glaucoma drugs maker Aerie. Via Investor's Business Daily Check your Portfolio for Small Cap Weighting: Growth, Innovation or Speculation? August 15, 2022 The SPDR S&P Biotech ETF remains our key indicator for small cap biotechs. It is up 14.55% over one month at $93.78 but is still down 16% YTD. The Russell 2000 is up 16.5% over one month mirroring... Via Talk Markets Why Jim Cramer Says This Financial Stock Is 'Terrific' August 12, 2022 On CNBC’s "Mad Money Lightning Round," Jim Cramer said The Charles Schwab Corporation (NYSE: SCHW) is "terrific." Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2022 August 10, 2022 Via Benzinga Earnings Preview: ChemoCentryx August 08, 2022 ChemoCentryx (NASDAQ:CCXI) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement. Analysts estimate that ChemoCentryx... Via Benzinga Small Cap Biotechs Perk Up On Dealmaking August 06, 2022 With M&A picking up we would think smaller deals make sense for large cap biopharma to expand pipelines and complement technology. Via Talk Markets Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review August 05, 2022 The Nasdaq and small caps rose while the S&P 500 is hitting resistance. Via Investor's Business Daily Where ChemoCentryx Stands With Analysts August 05, 2022 Over the past 3 months, 4 analysts have published their opinion on ChemoCentryx (NASDAQ:CCXI) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022 August 05, 2022 Upgrades Via Benzinga Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday August 05, 2022 U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is the list of some big stocks moving higher in the previous session. Via Benzinga Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday August 05, 2022 Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share... Via Benzinga Amgen Narrows Sales Outlook Following Plans To Acquire ChemoCentryx August 04, 2022 The company also reported a second-quarter beat and reiterated its earnings outlook. Via Investor's Business Daily Gold Tops 1,800; Alibaba Reports Upbeat Results August 04, 2022 U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 75 points on Thursday Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
